| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |